Residual iliofemoral thrombosis in a 31-year-old woman on oral contraceptives possessing heterozygous factor V Leiden, factor XIII Val34Leu allele and α-fibrinogen Thr312Ala allele

Polskie Archiwum Medycyny Wewnetrznej

Volumn 119, Issue 12, 2009, Pages 822-825

  Cieśla Dul, Mariola ^a,b   Gawȩda, Bogusław ^a,b   Wypasek, Ewa ^b   Rózańska, Maria ^c   Sadowski, Jerzy ^a,b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

^c Military Clinical Hospital Krakow   (Poland)

Author keywords

Fibrin; Iliofemoral thrombosis; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5 LEIDEN; DROSPIRENONE PLUS ESTRADIOL; ENOXAPARIN; ORAL CONTRACEPTIVE AGENT; UNCLASSIFIED DRUG; VENOMBIN A; YASMINELLE;

ADULT; ALLELE; ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; ARTICLE; CASE REPORT; DEEP VEIN THROMBOSIS; FEMALE; FIBRINOLYSIS; GENE MUTATION; HUMAN; MINIMAL RESIDUAL DISEASE; ORAL CONTRACEPTION; PHYSICAL EXAMINATION; RECANALIZATION; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOPHILIA;

EID: 75649123490     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.853     Document Type: Article

References (8)

1. Delis KT, Bountouroglou D, Mansfield AO. Venous claudication in iliofemoral thrombosis: long-term effects on venous hemodynamics, clinical status, and quality of life. Ann Surg. 2004; 239: 118-126.
2. Balogh I, Szo̊ke G, Kárpáti L, et al. Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia. Blood. 2000; 96: 2479-2486.
3. Carter AM, Catto AJ, Kohler HP, et al. Alpha fibrinogen Thr312Ala polymorphism and venous thromboembolism. Circulation. 2003; 107: 2326-2330.
4. [Prevention and treatment of venous thromboembolism: Polish Consensus 2008]. Acta Angiologica. 2008; 13 (Suppl C): C1-C22. Polish.
5. Siragusa S, Malato A, Anastasio R, et al. Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression Ultra-Sonography (DACUS) study. Blood. 2008; 112: 511-515.
6. Palareti G, Cosmi B, Legnani C, et al. PROLONG Investigators. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med. 2006; 355: 1780-1789.
7. Scott EM, Ariëns RAS, Grant PJ. Genetic and environmental determinants of fibrin structure and function. Relevance to clinical disease. ArteriosclerThromb Vasc Biol. 2004; 24: 1558-1566.
8. Negelen P, Hollis K, Olivier J, et al. Stenting of the venous outflow in chronic venous disease: long term stent-related outcome, clinical and hemodynamic results. J Vasc Surg. 2007; 46: 979-990.